Du är här


Novavax, Inc.: Novavax to Present at the Ladenburg Thalmann 2015 Healthcare Conference

GAITHERSBURG, Md., Sept. 21, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc.
(Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery,
development and commercialization of recombinant nanoparticle vaccines and
adjuvants, today announced that Stanley C. Erck, President and CEO, will
present at the Ladenburg Thalmann Healthcare 2015 Conference.

Conference details are as follows:

Date: Tuesday, September 29, 2015
Time: 1:30 - 1:55 p.m. US Eastern Time
Location: Sofitel Hotel, New York City
Live webcast: http://wsw.com/webcast/ladenburg/nvax

The webcast and a replay of the presentation will also be accessible under the
"Investors/Events" section of the Novavax website at novavax.com.

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to
delivering novel products to prevent a broad range of infectious diseases.
Our recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the
foundation for groundbreaking innovation that improves global health through
safe and effective vaccines. Additional information about Novavax is
available on the Company's website, novavax.com.

Novavax, Inc.

Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer

Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations


Russo Partners, LLC

David Schull
Todd Davenport, Ph.D.



This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novavax, Inc. via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.